# OnCo record greenwich-lifesciences (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/greenwich-lifesciences/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "greenwich-lifesciences" ;
  schema:name "Greenwich LifeSciences"@en ;
  schema:alternateName "Greenwich LifeSciences, Inc."@en, "NASDAQ:GLSI"@en ;
  schema:description "Greenwich LifeSciences is a Texas biotech running a phase 3 trial of GLSI-100, a HER2 peptide vaccine given after standard treatment to stop breast cancer coming back."@en ;
  schema:url <https://onco.cc/companies/greenwich-lifesciences/>, <https://www.greenwichlifesciences.com/> ;
  schema:dateModified "2026-09-17"^^xsd:date ;
  schema:citation <https://www.greenwichlifesciences.com/> ;
  onco:tag "drug-maker" ;
  schema:addressCountry "US" ;
  onco:drugs <https://onco.cc/drugs/glsi-100/> .